trending Market Intelligence /marketintelligence/en/news-insights/trending/729Vq35lFznicluxQzh1zA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Eleven Biotherapeutics plans common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Eleven Biotherapeutics plans common stock offering

Eleven Biotherapeutics Inc. plans to offer $12.5 million of its common stock.

The company plans to use the net proceeds to continue funding the clinical development of Vicinium and for general corporate purposes, which may include capital expenditures and funding our working capital needs.

H.C. Wainwright & Co. LLC will act as the sole book-running manager for this offering.